Neurotoxins licensed as treatment for neck neuromuscular disorder.
D001905:Botulinum Toxins / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004421:Dystonia / Q000188:drug therapy*; D006801:Humans; D019547:Neck Pain / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D009498:Neurotoxins / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D009465:Neuromuscular Agents; D009498:Neurotoxins; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A